ROIVANT

Serial Number 99121352
641

Registration Progress

Application Filed
Apr 4, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Non-Final Action Mailed
Due: Dec 03, 2025 26 days

Trademark Image

ROIVANT

Basic Information

Serial Number
99121352
Filing Date
April 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
641
Status Date
Sep 3, 2025
Application
Pending
Classes
005

Rights Holder

Roivant Sciences GmbH

99
Address
Viaduktstrasse 8
Basel 4051
CH

Ownership History

Roivant Sciences GmbH

Original Applicant
99
Basel CH

Legal Representation

Attorney
Joyce M. Ferraro

USPTO Deadlines

Next Deadline
26 days remaining
Non-Final Action Mailed
Due Date
December 03, 2025
Extension Available
Until March 03, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Sep 3, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 3, 2025 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Sep 3, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 4, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 4, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 4, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use for the treatment of central nervous system, neurological, dementia, dermatological, metabolic, hematologic, infectious, auto-immune, immune deficiency, genetic, hepatological, cardiometabolic, urological, oncological, endocrine and endocrine-related, gynecological, ophthalmological, respiratory, cardiac, and pulmonary disorders, diseases and conditions

Additional Information

Pseudo Mark
ROI VANT

Classification

International Classes
005